CasLoc logo
All Cases PTAB Litigations UPC Oppositions

Alza Corporation v. Impax Laboratories, Inc.

1:11-cv-00395

Overview

Case Number 1:11-cv-00395
Filing Date 2011-05-05
Status Terminated
Termination Date 2012-09-14
Court District Court, D. Delaware (ded)
Nature of Suit 830 Patent
Jurisdiction Type Federal Question
Cause of Action 35:271 Patent Infringement
Jury Demand None

Parties

Defendant

Impax Laboratories, Inc. Operating Company

Represented By

0 Attorneys Listed
No attorneys available

Plaintiff

Alza Corporation NPE (Individual / Inventor)

Represented By

0 Attorneys Listed
No attorneys available

Court & Judges

Court

District Court, D. Delaware (ded)

Global Patent Family Cross-Litigation Radar

CasLoc 360Β° Radar 16 Family Members

Multi-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions

πŸ‡ΊπŸ‡Έ
U.S. District Courts 3 proceedings
πŸ›οΈ
USPTO PTAB Trials Counterparts in force
πŸ‡ͺπŸ‡Ί
Unified Patent Court (UPC) Counterparts in force
πŸ‡©πŸ‡ͺ
European Patent Office (EPO) Counterparts in force
Worldwide Family Members (16): πŸ‡ΊπŸ‡Έ US
Parallel Proceedings Across Jurisdictions (3 found):
U.S. Courts: 3
U.S. District Court 2014-05-12
1:14-cv-00594

Alza Corporation v. Mylan Pharmaceuticals Inc.

U.S. Family Sibling (["US8163798"])
Status: DED
U.S. District Court 2013-06-24
1:13-cv-01126

Alza Corporation v. Osmotica Kereskedelmi es Szolgaltato Kft

Asserted Patent
Status: DED
U.S. District Court 2013-06-19
1:13-cv-01104

Alza Corporation v. Par Pharmaceutical Inc.

U.S. Family Sibling (["US8163798"])
Status: DED
Stay ahead of cross-border rulings. Subscribe for free automated docket alerts across U.S. Courts, PTAB, UPC, and EPO.

Patents Involved

1 Patent

There is a single patent involved in this case.

Patent Asset Filing & Issue Date Expiration & Term Status External Links
US6930129
Methods and devices for providing prolonged drug therapy
Filed: 2001-03-08
Issued: 2005-08-16
Expired (Term Ended)
Expires: 2017-11-21

Patent Enforceability & Injunction Risk Assessment

Statutory Analysis
Injunction Viability (35 U.S.C. Β§ 283) Statutorily Barred

Statutorily Barred β€” Patent expired. Under 35 U.S.C. Β§ 283, injunctive relief is barred.

Terminal Disclaimer & Cellect Risk Low Risk

Standard Statutory Term β€” No obviousness-type double patenting noted.

Damages Lookback Horizon 6-Yr Max Lookback

Under 35 U.S.C. Β§ 286, damages cannot accrue for infringement prior to 6 years before filing. All Statutory Maintenance Fees Paid (12-Year Window Cleared).

Docket Entries

(9 total)
Pleading / Complaint

Complaint

Entry #1 • 2011-05-05
1

Exhibit A

Entry #1 • 2011-05-05
2

Civil Cover Sheet

Entry #1 • 2011-05-05
2

Magistrate Consent Forms

Entry #2 • 2011-05-05
1

Patent/Trademark Report to Commissioner

Entry #3 • 2011-05-05
1

Track Case Updates

Automated email notifications for new filings & decisions

Identifier: •

Free service • 1-click unsubscribe anytime • Powered by CasLoc